Aggregation modulators interfere with membrane interactions of β2-microglobulin fibrils

Biophysical Journal

Volumn 105, Issue 3, 2013, Pages 745-755

  Sheynis, Tania ^a,b   Friediger, Anat ^a   Xue, Wei Feng ^b,c   Hellewell, Andrew L ^b   Tipping, Kevin W ^b   Hewitt, Eric W ^b   Radford, Sheena E ^b   Jelinek, Raz ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; HEPARIN; LIPOSOME; POLYPHENOL;

ARTICLE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; POLYMERIZATION; PROTEIN BINDING;

BETA 2-MICROGLOBULIN; CATECHIN; CELL MEMBRANE; HEPARIN; HUMANS; POLYMERIZATION; POLYPHENOLS; PROTEIN BINDING; UNILAMELLAR LIPOSOMES;

EID: 84881457232     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2013.06.015     Document Type: Article

References (61)

1. Y. Huang, and L. Mucke Alzheimer mechanisms and therapeutic strategies Cell 148 2012 1204 1222
2. W.G. Meissner, and M. Frasier E. Bezard Priorities in Parkinson's disease research Nat. Rev. Drug Discov. 10 2011 377 393
3. M. Stefani Generic cell dysfunction in neurodegenerative disorders: role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity Neuroscientist 13 2007 519 531
4. S. Campioni, and B. Mannini F. Chiti A causative link between the structure of aberrant protein oligomers and their toxicity Nat. Chem. Biol. 6 2010 140 147
5. A.R. Ladiwala, and J. Litt P.M. Tessier Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity J. Biol. Chem. 287 2012 24765 24773
6. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 2003 267 298
7. B. Winner, and R. Jappelli R. Riek In vivo demonstration that α-synuclein oligomers are toxic Proc. Natl. Acad. Sci. USA 108 2011 4194 4199
8. M. Bucciantini, and E. Giannoni M. Stefani Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
9. I.H. Cheng, and K. Scearce-Levie L. Mucke Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models J. Biol. Chem. 282 2007 23818 23828
10. L. Pieri, and K. Madiona R. Melki Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells Biophys. J. 102 2012 2894 2905
11. W.F. Xue, and A.L. Hellewell S.E. Radford Fibril fragmentation enhances amyloid cytotoxicity J. Biol. Chem. 284 2009 34272 34282
12. T. Okada, and K. Ikeda K. Matsuzaki Formation of toxic Aβ (1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Aβ(1-40) fibrils J. Mol. Biol. 382 2008 1066 1074
13. W.F. Xue, and A.L. Hellewell S.E. Radford Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters Prion 4 2010 20 25
14. P.H. Ren, and J.E. Lauckner R.R. Kopito Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates Nat. Cell Biol. 11 2009 219 225
15. K.C. Luk, and V. Kehm V.M. Lee Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice Science 338 2012 949 953
16. J.Y. Li, and E. Englund P. Brundin Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation Nat. Med. 14 2008 501 503
17. N. Cremades, and S.I. Cohen D. Klenerman Direct observation of the interconversion of normal and toxic forms of α-synuclein Cell 149 2012 1048 1059
18. I.C. Martins, and I. Kuperstein F. Rousseau Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice EMBO J. 27 2008 224 233
19. P.K. Auluck, G. Caraveo, and S. Lindquist α-Synuclein: membrane interactions and toxicity in Parkinson's disease Annu. Rev. Cell Dev. Biol. 26 2010 211 233
20. R. Jelinek Lipids and Cellular Membranes in Amyloid Diseases 2011 Wiley-VCH Weinheim, Germany
21. A.S. Pithadia, and A. Kochi M.H. Lim Reactivity of diphenylpropynone derivatives toward metal-associated amyloid-β species Inorg. Chem. 51 2012 12959 12967
22. P.N. Cheng, and C. Liu J.S. Nowick Amyloid β-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity Nat. Chem. 4 2012 927 933
23. T. Härd, and C. Lendel Inhibition of amyloid formation J. Mol. Biol. 421 2012 441 465
24. Y.S. Han, and W.H. Zheng R. Quirion Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C Br. J. Pharmacol. 141 2004 997 1005
25. F. Evers, and C. Jeworrek R. Winter Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron x-ray reflectivity study J. Am. Chem. Soc. 131 2009 9516 9521
26. K. Rezai-Zadeh, and G.W. Arendash J. Tan Green tea epigallocatechin-3- gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice Brain Res. 1214 2008 177 187
27. D.E. Ehrnhoefer, and M. Duennwald E.E. Wanker Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models Hum. Mol. Genet. 15 2006 2743 2751
28. D.E. Ehrnhoefer, and J. Bieschke E.E. Wanker EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 2008 558 566
29. A.R. Ladiwala, and J.C. Lin P.M. Tessier Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Aβ into off-pathway conformers J. Biol. Chem. 285 2010 24228 24237
30. F. Meng, and A. Abedini D.P. Raleigh The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity Biochemistry 49 2010 8127 8133
31. R. Lever, and C.P. Page Novel drug development opportunities for heparin Nat. Rev. Drug Discov. 1 2002 140 148
32. R. Bravo, and M. Arimon X. Fernàndez-Busquets Sulfated polysaccharides promote the assembly of amyloid β (1-42) peptide into stable fibrils of reduced cytotoxicity J. Biol. Chem. 283 2008 32471 32483
33. M. Pérez, and F. Wandosell J. Avila Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment Biochem. J. 335 1998 369 374
34. G. Liu, and P. Men M.A. Smith Nanoparticle-chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease Neurosci. Lett. 455 2009 187 190
35. B. Mannini, and R. Cascella F. Chiti Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers Proc. Natl. Acad. Sci. USA 109 2012 12479 12484
36. A.R. Ladiwala, and M. Bhattacharya P.M. Tessier Rational design of potent domain antibody inhibitors of amyloid fibril assembly Proc. Natl. Acad. Sci. USA 109 2012 19965 19970
37. A.M. Saraiva, and I. Cardoso G. Brezesinski Controlling amyloid-β peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles ChemBioChem 11 2010 1905 1913
38. T. Högen, and J. Levin A. Giese Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state Biophys. J. 102 2012 1646 1655
39. W.P. Burmeister, and L.N. Gastinel P.J. Bjorkman Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor Nature 372 1994 336 343
40. V. Bellotti, and M. Stoppini G. Ferri β2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils Eur. J. Biochem. 258 1998 61 67
41. M.Y. Porter, and K.E. Routledge E.W. Hewitt Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils PLoS ONE 6 2011 e27353
42. D.E. Stevenson, and R.D. Hurst Polyphenolic phytochemicals - just antioxidants or much more? Cell. Mol. Life Sci. 64 2007 2900 2916
43. C.J. Jones, and S. Beni C.K. Larive Heparin characterization: challenges and solutions Annu. Rev. Anal. Chem. 4 2011 439 465
44. A. Moscho, and O. Orwar R.N. Zare Rapid preparation of giant unilamellar vesicles Proc. Natl. Acad. Sci. USA 93 1996 11443 11447
45. G. Parisio, and A. Marini B. Mennucci Polarity-sensitive fluorescent probes in lipid bilayers: bridging spectroscopic behavior and microenvironment properties J. Phys. Chem. B 115 2011 9980 9989
46. E. Bazar, and R. Jelinek Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant ChemBioChem 11 2010 1997 2002
47. S.L. Myers, and S. Jones S.E. Radford A systematic study of the effect of physiological factors on β2-microglobulin amyloid formation at neutral pH Biochemistry 45 2006 2311 2321
48. S. Yamamoto, and I. Yamaguchi H. Naiki Glycosaminoglycans enhance the trifluoroethanol-induced extension of β 2-microglobulin-related amyloid fibrils at a neutral pH J. Am. Soc. Nephrol. 15 2004 126 133
49. R.F. Chen, and J.R. Knutson Mechanism of fluorescence concentration quenching of carboxyfluorescein in liposomes: energy transfer to nonfluorescent dimers Anal. Biochem. 172 1988 61 77
50. H.E. White, and J.L. Hodgkinson H.R. Saibil Globular tetramers of β (2)-microglobulin assemble into elaborate amyloid fibrils J. Mol. Biol. 389 2009 48 57
51. J. Larsen, N.S. Hatzakis, and D. Stamou Observation of inhomogeneity in the lipid composition of individual nanoscale liposomes J. Am. Chem. Soc. 133 2011 10685 10687
52. Y.S. Han, and S. Bastianetto R. Quirion Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain J. Pharmacol. Exp. Ther. 318 2006 238 245
53. Y. Sun, and W.C. Hung H.W. Huang Interaction of tea catechin (-)-epigallocatechin gallate with lipid bilayers Biophys. J. 96 2009 1026 1035
54. L. Milanesi, and T. Sheynis H.R. Saibil Direct three-dimensional visualization of membrane disruption by amyloid fibrils Proc. Natl. Acad. Sci. USA 109 2012 20455 20460
55. E. Pebay-Peyroula, E.J. Dufourc, and A.G. Szabo Location of diphenyl-hexatriene and trimethylammonium-diphenyl-hexatriene in dipalmitoylphosphatidylcholine bilayers by neutron diffraction Biophys. Chem. 53 1994 45 56
56. C. Rodrigues, and P. Gameiro B. de Castro Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies Biochim. Biophys. Acta 1620 2003 151 159
57. S. Vilasi, and R. Sarcina I. Sirangelo Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro PLoS ONE 6 2011 e22076
58. M.F. Sciacca, and S.A. Kotler A. Ramamoorthy Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation Biophys. J. 103 2012 702 710
59. L.A. Woods, and G.W. Platt S.E. Radford Ligand binding to distinct states diverts aggregation of an amyloid-forming protein Nat. Chem. Biol. 7 2011 730 739
60. T.L. Williams, and L.C. Serpell Membrane and surface interactions of Alzheimer's Aβ peptide - insights into the mechanism of cytotoxicity FEBS J. 278 2011 3905 3917
61. SciFinder. 2013. Physical properties of molecules used in the study http://www.scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf Accessed January 2013.